Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.23.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2022
Jan. 01, 2022
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts receivable $ 4,549 $ 5,449
Common stock, shares authorized (in shares) 825,000,000 825,000,000
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares issued (in shares) 146,703,894 146,561,717
Common stock, shares outstanding (in shares) 146,703,894 146,561,717